Outcome of Patients With ≥70% Symptomatic Intracranial Stenosis After Wingspan Stenting
Author(s) -
Weijian Jiang,
Wengui Yu,
Bin Du,
Feng Gao,
Liying Cui
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.595926
Subject(s) - medicine , stenosis , wingspan , stroke (engine) , aspirin , warfarin , antithrombotic , cohort , surgery , clinical endpoint , randomized controlled trial , cardiology , atrial fibrillation , mechanical engineering , engineering , aerodynamics , aerospace engineering
There were limited data on the long-term outcome of patients with symptomatic intracranial atherosclerotic stenosis ≥70% after Wingspan stenting. Using our Wingspan cohort data and the data from the Warfarin and Aspirin for Symptomatic Intracranial Atherosclerotic Disease (WASID) as a historical control, we tested the hypothesis that stenting provided no benefit over antithrombotic therapy alone for these high-risk patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom